Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

PARP-1-induced cell death requires NAD+ depletion and mitochondrial permeability transition

R. Swanson, C. Alano, W. Ying

Med Sci Monit 2003; 9(1): 66-0 :: ID: 15205

Abstract

Mitochondrial permeability transition (MPT) leads to cell death in ischemia and inflammation [1]. Here we show that PARP-1 causes cell death through a process involving NAD+ depletion and mitochondrial permeability transition. PARP-1 activation in cultured mouse neurons or astrocytes led to delayed mitochondrial membrane depolarization and to MPT. These changes were prevented in PARP-1 deficient cells, with PARP inhibitors, or with sub-micromolar concentrations of MPT inhibitors, but not by the calcineurin inhibitor FK506. PARP-1-induced cell death was similarly blocked by MPT inhibitors but not FK506. Translocation of AIF from mitochondria to the nucleus, which has previously been linked PARP-1-induced cell death [2], did not occur when MPT was prevented. Last, repletion of intracellular NAD+ concentrations in PARP-1 activated cells prevented MPT, AIF translocation, and cell death. These results suggest that the NAD+ depletion is an upstream event in the PARP-1 cell death pathway, with NAD+ depletion leading to MPT, and MPT in turn leading to AIF translocation and cell death. References: 1.Halestrap AP: The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp, 1999; 66: 181-203 2.Yu SW, Wang H, Poitras MF et al: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 2002; 297: 259-263

Keywords: AIF, nicotinamide adenine dinucleotide, cyclosporin, membrane potential

Add Comment 0 Comments

Editorial

01 February 2025 : Editorial  

Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-Smokers

Dinah V. Parums

DOI: 10.12659/MSM.948255

Med Sci Monit 2025; 31:e948255

0:00

In Press

Clinical Research  

Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemi...

Med Sci Monit In Press; DOI: 10.12659/MSM.946303  

Clinical Research  

Long-Term Outcomes of Implanon in Managing Adenomyosis: A 3-Year Prospective Study

Med Sci Monit In Press; DOI: 10.12659/MSM.945972  

Laboratory Research  

Linear Dimensional Accuracy in Maxillomandibular Records: A Comparative Study of Scannable and Transparent ...

Med Sci Monit In Press; DOI: 10.12659/MSM.947265  

Clinical Research  

Efficacy of King's Combined Uterine Suture in Managing Placenta Accreta: A Retrospective Analysis

Med Sci Monit In Press; DOI: 10.12659/MSM.945826  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,969,932

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   701,896

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   25,741

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   20,253

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750